Last $35.37 USD
Change Today -0.36 / -1.01%
Volume 159.6K
NUVA On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 10/22/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for nuvasive inc (NUVA)

Although debt as a percent of total capital decreased at NuVasive, Inc. over the last fiscal year to 36.41%, it is still in-line with the Healthcare Equipment and Supplies industry's norm. Additionally, there are enough liquid assets to satisfy current obligations. Accounts Receivable are typical for the industry, with 51.60 days worth of sales outstanding. Last, NuVasive, Inc. is among the most efficient in its industry at managing inventories, with only 278.43 days of its Cost of Goods Sold tied up in inventory.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Reclassified
Dec 31
2011
Reclassified
Dec 31
2012
Reclassified
Dec 31
2013
4 Year
Trend
Assets    
Cash and Equivalents92.6163.5123.3102.8
Short-Term Investments86.5146.2138.4143.4
TOTAL CASH AND SHORT TERM INVESTMENTS179.1309.7261.7246.3
Accounts Receivable74.487.789.0104.8
TOTAL RECEIVABLES74.487.789.0104.8
Inventory107.6119.3126.4136.9
Prepaid Expenses6.420.58.510.9
Deferred Tax Assets, Current4.454.628.237.1
TOTAL CURRENT ASSETS371.8591.8513.7536.0
Gross Property Plant and Equipment184.1227.3251.6277.3
Accumulated Depreciation-81.9-102.5-126.5-149.3
NET PROPERTY PLANT AND EQUIPMENT102.2124.8125.1128.1
Goodwill103.1159.3154.1154.9
Long-Term Investments50.632.584.479.8
Deferred Tax Assets, Long Term52.019.940.642.9
Other Intangibles107.1108.1101.494.0
Other Long-Term Assets15.287.1144.5143.9
TOTAL ASSETS802.01,123.61,163.81,179.6
    
LIABILITIES & EQUITY    
Accounts Payable14.511.39.014.3
Accrued Expenses61.061.379.3100.4
Current Portion of Long-Term Debt/Capital Lease----74.3--
Other Current Liabilities, Total33.4134.81.62.5
TOTAL CURRENT LIABILITIES109.0207.4164.3117.2
Long-Term Debt230.0394.0332.4346.1
Capital Leases--0.90.40.2
Minority Interest11.910.710.09.1
Deferred Tax Liability Non-Current3.74.03.12.9
Other Non-Current Liabilities13.112.6116.0108.3
TOTAL LIABILITIES355.8618.8616.2574.7
Common Stock0.00.00.00.0
Additional Paid in Capital545.1674.8714.9769.2
Retained Earnings-111.4-181.3-178.1-170.2
Comprehensive Income and Other0.60.50.8-3.2
TOTAL COMMON EQUITY434.4494.0537.6595.8
TOTAL EQUITY446.2504.8547.6604.9
TOTAL LIABILITIES AND EQUITY802.01,123.61,163.81,179.6
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NUVA:US $35.37 USD -0.36

NUVA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CONMED Corp $39.31 USD -0.65
Globus Medical Inc $20.51 USD +0.53
Integra LifeSciences Holdings Corp $48.86 USD -0.99
Thoratec Corp $26.02 USD -0.49
Wright Medical Group Inc $31.51 USD -0.04
View Industry Companies
 

Industry Analysis

NUVA

Industry Average

Valuation NUVA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.3x
Price/Book 2.7x
Price/Cash Flow 193.7x
TEV/Sales 1.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NUVASIVE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.